ALCEAlternus Clean Energy Inc
The schedule
- Sat14Nov
First assessment of Q3 cash burn, project viability, and going concern status amid a deteriorating balance sheet with shares anchored at $0.10.
- Wed20Jan
Expected timeline for a highly dilutive equity offering or toxic debt-for-equity swap to avoid insolvency, evaluated from a $0.05 baseline.
- Tue30Mar
Full-year results and crucial audit opinion regarding ALCE's ability to continue as a going concern, assessing the $0.02 level.
- Fri14May
First-quarter operational update and potential Nasdaq minimum bid price compliance resolution, starting from $0.01.
- Sat14Aug
Mid-year 2027 operational update testing the viability of ALCE's asset portfolio, assuming a $0.005 entry point.
Past
- Wed1Jul
Actual outcome: Bull
ALCE experienced a massive upward move due to the unexpected regulatory approval of its flagship product, which had been pending for several months. The approval significantly expanded its market access and validated its technology, leading to a surge in investor confidence and valuation re-rating. [Market retrospective · Long-Term (31–75 days)] Updated observation 2026-09-14: +10400.0% from 2026-04-28 (~27.2σ). Target date 2026-07-22 reached; move through 2026-09-14 observed.
ALCE experienced a massive upward move due to the unexpected regulatory approval of its flagship product, which had been pending for several months. The approval significantly expanded its market access and validated its technology, leading to a surge in investor confidence and valuation re-rating. [Market retrospective · Long-Term (31–75 days)] Updated observation 2026-09-14: +10400.0% from 2026-04-28 (~27.2σ). Target date 2026-07-22 reached; move through 2026-09-14 observed.
